Khaled El-Adl

40PUBLICATIONS
37CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsChemotherapyBiomolecular modelling and designBiologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Mar 12, 2026
Pyrazole/pyrimidine derivatives endowed with azobenzenes as dual EGFRT790M and VEGFR-2 inhibitors: anticancer, docking, synthesis, design and ADMET assessments.

Kurls E Anwer, Mohamed A Abdelgawad, Felemban Athary Abdulhaleem M

|Feb 20, 2026
Pyrazolo[3,4-d]pyrimidine derivatives as VEGFR-2 and EGFRT790M dual inhibitors: design, docking, ADMET, synthesis and anticancer evaluations.

Nada A A M Aziz, Riham F George, Tamer Nasr

|Sep 12, 2025
A two-decade overview of oxadiazole derivatives as promising anticancer agents.

Mo'men Salem, Khaled El-Adl, Ahmed El-Morsy

|Apr 02, 2025
Design, nanogel synthesis, anti-proliferative activity and in silico ADMET profile of pyrazoles and pyrimidines as topo-II inhibitors and DNA intercalators.

Ahmed K B Aljohani, Sanadelaslam S A El-Hddad, Marwa Alsulaimany

|Mar 24, 2025
A decade of research effort in synthesis, biological activity assessments, and mechanistic investigations of sulfamethazine-incorporating molecules.

Hamada S Abulkhair, Khaled El-Adl

|Jan 17, 2025
Dual VEGFR-2 and EGFRT790M inhibitors of phenyldiazenes: anticancer evaluations, ADMET, docking, design and synthesis.

Marwa Alsulaimany, Ahmed K B Aljohani, Nour E A Abd El-Sattar

Pageof 7

Frequent Collaborators

11 joint publications

Hamada S Abulkhair

9 joint publications

Ibrahim H Eissa

3 joint publications

Hatem Hussein Bayoumi

3 joint publications

Nour E A Abd El-Sattar